HR1003
To Designate May 5-11, 2024 As "tardive Dyskinesia Awareness Week".
Last Action (April 16, 2024): READ AND ADOPTED.
Sponsors
AI-Generated Summary
House Resolution 1003 is a formal act of the Arkansas House of Representatives that designates May 5-11, 2024, as 'Tardive Dyskinesia Awareness Week.' The resolution acknowledges the condition of tardive dyskinesia (TD), an involuntary movement disorder that can result from the use of certain dopamine receptor blocking medications often prescribed for mental health or gastrointestinal issues. The document emphasizes the importance of early diagnosis, medical monitoring, and awareness of available treatments approved by the FDA. Additionally, the resolution encourages individuals experiencing symptoms of involuntary, repetitive movements to consult with healthcare professionals. This measure serves primarily as a public advocacy and educational tool.
Potential Impact Analysis
Who Might Benefit?
The primary beneficiaries are individuals living with tardive dyskinesia, as the resolution aims to increase public and medical awareness, potentially leading to higher rates of diagnosis and treatment. Additionally, patients currently taking dopamine receptor blocking medications may benefit from increased awareness, which could lead to earlier clinical monitoring and improved patient safety.
Who Might Suffer?
There are no identifiable groups or entities that would be negatively impacted by this resolution, as it is a non-binding legislative act intended solely for public awareness and does not impose new regulations, taxes, or legal burdens on any party.
Get Notified
Receive an email when this bill's status changes.